The high heterogeneity of breast cancer is primarily due to the presence of several molecular subtypes that can be distinguished by the expression of estrogen receptor (ERα), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is breast carcinoma.